SEC Form 4 · accession 0001209191-18-025840
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Joseph
Officer — Chief Legal Officer and Secy
Period of report
Apr 20, 2018
Accepted (ET)
Apr 23, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $18.53 | Apr 20, 2018 | A | 60,000 | A | — | Apr 20, 2028 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable over four years as follows: 25% of the shares vest on April 20, 2019, and the remaining 75% vesting quarterly over the remaining three years.